These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 35409372)

  • 1. Enhanced Magnetic Hyperthermia of Magnetoferritin through Synthesis at Elevated Temperature.
    Yu J; Cao C; Fang F; Pan Y
    Int J Mol Sci; 2022 Apr; 23(7):. PubMed ID: 35409372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of biocompatible and ultrastable superparamagnetic iron(III) oxide nanoparticles doped with magnesium for efficient magnetic fluid hyperthermia in lung cancer cells.
    Nowicka AM; Ruzycka-Ayoush M; Kasprzak A; Kowalczyk A; Bamburowicz-Klimkowska M; Sikorska M; Sobczak K; Donten M; Ruszczynska A; Nowakowska J; Grudzinski IP
    J Mater Chem B; 2023 May; 11(18):4028-4041. PubMed ID: 36960952
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Experimental Evaluation on the Heating Efficiency of Magnetoferritin Nanoparticles in an Alternating Magnetic Field.
    Xu H; Pan Y
    Nanomaterials (Basel); 2019 Oct; 9(10):. PubMed ID: 31615049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Magnetoferritin: Process, Prospects, and Their Biomedical Applications.
    Xue L; Deng D; Sun J
    Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31100837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relaxivity properties of magnetoferritin: The iron loading effect.
    Aslan TN
    J Biosci Bioeng; 2022 May; 133(5):474-480. PubMed ID: 35277341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Magnetoferritin enhances T
    Kumar A; Nandwana V; Ryoo SR; Ravishankar S; Sharma B; Pervushin K; Dravid VP; Lim S
    Mater Sci Eng C Mater Biol Appl; 2021 Sep; 128():112282. PubMed ID: 34474835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High therapeutic efficiency of magnetic hyperthermia in xenograft models achieved with moderate temperature dosages in the tumor area.
    Kossatz S; Ludwig R; Dähring H; Ettelt V; Rimkus G; Marciello M; Salas G; Patel V; Teran FJ; Hilger I
    Pharm Res; 2014 Dec; 31(12):3274-88. PubMed ID: 24890197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantification of Iron Release from Native Ferritin and Magnetoferritin Induced by Vitamins B
    Strbak O; Balejcikova L; Kmetova M; Gombos J; Trancikova A; Pokusa M; Kopcansky P
    Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32878313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Magnetoferritin: characterization of a novel superparamagnetic MR contrast agent.
    Bulte JW; Douglas T; Mann S; Frankel RB; Moskowitz BM; Brooks RA; Baumgarner CD; Vymazal J; Strub MP; Frank JA
    J Magn Reson Imaging; 1994; 4(3):497-505. PubMed ID: 7802866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimization Study on Specific Loss Power in Superparamagnetic Hyperthermia with Magnetite Nanoparticles for High Efficiency in Alternative Cancer Therapy.
    Caizer C
    Nanomaterials (Basel); 2020 Dec; 11(1):. PubMed ID: 33375292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single and Dual Surfactants Coated Hydrophilic Superparamagnetic Iron Oxide Nanoparticles for Magnetic Fluid Hyperthermia Applications.
    Sudame A; Kandasamy G; Maity D
    J Nanosci Nanotechnol; 2019 Jul; 19(7):3991-3999. PubMed ID: 30764960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of the Magnetic Hyperthermia Response Using Different Superparamagnetic Iron Oxide Nanoparticle Morphologies.
    Reyes-Ortega F; Delgado ÁV; Iglesias GR
    Nanomaterials (Basel); 2021 Mar; 11(3):. PubMed ID: 33802441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hierarchical self-assembly and optical disassembly for controlled switching of magnetoferritin nanoparticle magnetism.
    Kostiainen MA; Ceci P; Fornara M; Hiekkataipale P; Kasyutich O; Nolte RJ; Cornelissen JJ; Desautels RD; van Lierop J
    ACS Nano; 2011 Aug; 5(8):6394-402. PubMed ID: 21761851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Using kinetic Monte Carlo simulations to design efficient magnetic nanoparticles for clinical hyperthermia.
    Papadopoulos C; Kolokithas-Ntoukas A; Moreno R; Fuentes D; Loudos G; Loukopoulos VC; Kagadis GC
    Med Phys; 2022 Jan; 49(1):547-567. PubMed ID: 34724215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation between effects of the particle size and magnetic field strength on the magnetic hyperthermia efficiency of dextran-coated magnetite nanoparticles.
    Shaterabadi Z; Nabiyouni G; Soleymani M
    Mater Sci Eng C Mater Biol Appl; 2020 Dec; 117():111274. PubMed ID: 32919638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thermostable iron oxide nanoparticle synthesis within recombinant ferritins from the hyperthermophile
    Yu J; Zhang T; Xu H; Dong X; Cai Y; Pan Y; Cao C
    RSC Adv; 2019 Nov; 9(67):39381-39393. PubMed ID: 35540659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N-Hydroxysuccinamide functionalized iron oxide nanoparticles conjugated with 5-flurouracil for hyperthermic therapy of malignant liver cancer cells by DNA repair disruption.
    Veeramani S; Chandrababu L; Rajangam I; Singh NR; Al-Humaid L; Al-Dahmash ND; Balaji R; Chandrasekar N; Hwang MT
    Int J Biol Macromol; 2023 Oct; 250():126001. PubMed ID: 37532190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic evaluation of magnetic hyperthermia using Fe3O4-aminosilane-coated iron oxide nanoparticles in glioblastoma animal model.
    Rego GNA; Mamani JB; Souza TKF; Nucci MP; Silva HRD; Gamarra LF
    Einstein (Sao Paulo); 2019 Aug; 17(4):eAO4786. PubMed ID: 31390427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyperthermia of Magnetically Soft-Soft Core-Shell Ferrite Nanoparticles.
    Narayanaswamy V; Jagal J; Khurshid H; Al-Omari IA; Haider M; Kamzin AS; Obaidat IM; Issa B
    Int J Mol Sci; 2022 Nov; 23(23):. PubMed ID: 36499152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis of Cationized Magnetoferritin for Ultra-fast Magnetization of Cells.
    Correia Carreira S; Armstrong JP; Okuda M; Seddon AM; Perriman AW; Schwarzacher W
    J Vis Exp; 2016 Dec; (118):. PubMed ID: 28060256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.